Bookings surge for Osirium Technologies

6

Cloud-based cybersecurity provider Osirium Technologies (LON: OSI) says 2022 revenues will be £1.9m, up from £1.4m in 2021. The share price fell 7.5% to 3.7p, but the AIM-quoted company is still two-fifths higher than at the start of the year.

The revenues are slightly higher than forecast and the bookings taken in recent months indicate that the 2023 revenues forecast of £2.3m could be beaten. There were bookings of at least £3m during 2022, up from £1.6m in 2021, so that provides a good base for 2023. Deferred revenues are £2.7m.

Annual recurring revenues are £1.8m. The initial value of new contracts is nearly double the level one year ago.

There is £1.1m in cash following the November placing raising £1.53m at 2p a share. Annualised cost savings of £1m were identified at that time. That helps to reduce the cash breakeven level, but Osirium Technologies will still lose money in 2022 and 2023.

Hydrogen Utopia International makes standard switch

Hydrogen Utopia International (LON: HUI) has made its move from the Aquis Stock Exchange to the standard list. The waste-to-energy facilities developer started the day at 16.625p and closed at 16.75p (16.5p/17p) with nearly 765,000 shares dealt in 21 trades on the standard list.
Hydrogen Utopia raised £3m at 7.5p when it joined the Access segment of Aquis on 6 January 2021, so last Friday was its first anniversary and its last day of trading on the Access Segment. However, it is now listed on the Aquis Main Market.
There are not many companies that have an additional listing on that market, bu...

Ocado leads FTSE 100 ahead of retail company Christmas updates

Ocado was the FTSE 100’s top riser in afternoon trade on Monday ahead of a raft of Christmas updates from Tesco, Sainsbury’s and JD Sports this week.

Ocado themselves are set to provide a trading update next week.

UK retail companies have so far provided reasonably positive Christmas trading updates with Next and Greggs producing robust figures last week. In the face of concerns about the cost of living crisis, the FTSE 100’s consumer-facing companies have had a strong start to the year and are among the FTSE 100’s best performers in the new year.

Ocado shares are up 21% this year while Sainsbury’s and JD Sports have gained 13% and 11% respectively. The worst performers so far in 2023 are Centrica and Pearson, both down in the region of 5%.

FTSE 100 hits 4-year highs

The FTSE 100 momentarily traded at the highest level for four years on Monday, before falling back to 7,698, down 0.05%, at the time of writing.

A strong US jobs number last week ignited a rally in US stocks which continued into early European trade on Monday.

“The FTSE 100 briefly touched four-year highs as the trading week got away – a significant milestone and some way above where it was in the weeks before the pandemic hit in 2020,” said AJ Bell investment director Russ Mould.

“Although US jobs figures came in above expectations at the end of last week, suggesting the labour market is still tight, investors seem to have focused on wage growth coming in slightly below what had been pencilled in. From their perspective that might prompt the Fed to slow its rate rises, hence the positive market reaction to the figures.

“Further easing of China’s Covid measures, despite surging cases in the country, have also helped create a happier mood.”

Miners were among the beneficiaries of improving Chinese sentiment with Glencore and Antofagasta moving higher. Both miners are particularly exposed to copper, which has rallied as the Chinese economy reopens.

AIM movers: Physiomics completes study for dosing tool and poor Christmans for Frontier Developments

3

Physiomics (LON: PYC) has completed a grant-funded PARTNER study. This was an observational trial run by the University of Portsmouth that collected data from prostate cancer patients treated with docetaxel. The data will help clinicians make decisions about dosage. Physiomics is exploring other uses for its personalised dosing tool. The share price jumped by 88.7% to 5.85p.

musicMagpie (LON: MMAG) subsidiary decluttr has secured a partnership with Walmart.com to supply it with pre-owned DVDs and games. The website has 120 million visitors/month. Refurbished technology will be added later. The share price is 14.7% higher at 32.7p.

Renalytix (LON: RENX) is installing its KidneyIntelX diagnostic tool inside the Veterans Health Administration cloud infrastructure. That will take 18 months and should accelerate take up. There are 960,000 veterans with chronic kidney disease and the cost of managing the patients is $19bn/year. The share price recovered by 13.5% to 105p.

GCM Resources (LON: GCM) has secured a joint development agreement with PowerChina International and Dyani Corporation for a greenfield solar project, which would be an adjunct to the proposed Phulbari coal and power project in Bangladesh. The share price increased by 13.2% to 5.15p.  

Poolbeg Pharma (LON: POLB) has published a further update on the Lipopolysaccharide human challenge clinical trial for influenza treatment POLB 001. There was a material reduction in systemic and localised inflammatory response compared to the placebo. The full results will be published in the second quarter. The share price moved 10.3% higher at 8.05p.

Video games publisher Frontier Developments (LON: FDEV) had a poor end to 2022 and it has downgraded guidance for the year to May 2023. This is down to a poor performance by F1 Manager 2022. The share price dived 39.7% to 602.5p. Full year revenues guidance has been reduced from £135m to £100m-£114m. Interim revenues will be 16% higher at £57m and second half revenues will be lower than the corresponding period last year. Cash was £42.6m at the end of November 2022. Management is considering the future of the Frontier Foundry games label.

Frontier Developments is not alone in its sector because Devolver Digital (LON: DEVO) sales were also disappointing at the end of 2022. Although revenues were within the guidance range, Zeus has cut its underlying 2022 EBITDA forecast by 28% to $21.7m. There will also be an impairment of capitalised development spending in the accounts. The 2023 forecast EBITDA has been cut by one-third to $22.8m. The share price fell 12.6% to 55.5p, which is a new low. Other video games companies also have falling share prices. Team17 (LON:TM17) slipped 8% to 430p and tinyBuild (LON: TBLD) is down 4.62% to 99.2p.

It is not just video games companies that had a weak end to the year. Animal feed additives supplier Anpario (LON: ANP) had a bad December. Shipping problems and China lockdowns hampered progress. Peel Hunt forecasts a fall in pre-tax profit from £5.8m to £3.9m in 2022. Net cash is £13.6m. Trading is likely to remain difficult, but profit should recover as raw material costs reduce. The share price is 11.6% lower at 420p.

Anglo Asian Mining makes additional investment in Libero Copper & Gold Corporation

Anglo Asian Mining have made their third investment in Libero Copper & Gold Corporation as part of a placing to maintain their 19.8% stake in the company.

 Anglo Asian Mining subscribed for 2.6 million new Libero Copper & Gold Corporation shares at CAN 15 cents per share for a total of CAN$390,000 (US$289,000).

Anglo Asian Mining have sought additional exposure to copper and Libero’s exploration projects with their investment in the TSX-listed company. Libber’s exposure includes Mocoa, one of the world’s largest undeveloped copper-molybdenum resources.

Anglo Asian Mining is one of the leading gold and copper producers in Azerbaijan. The company said they expect production of between 54,000oz to 58,000oz gold in 2022.

“We are pleased to make a third investment in Libero in little over a year. With an exciting range of significant copper assets across the Americas, and an experienced management team, we have the upmost confidence in Libero to develop these assets in a swift and responsible manner,” said Anglo Asian CEO Reza Vaziri.

“I look forward to updating our shareholders on Libero’s progress in the coming months.”

Tortilla Mexican Grill: Update confirms full year performing to market expectations

Richard Morris, Chief Executive of Tortilla Mexican Grill (LON:MEX), in announcing a Trading Update for the full year to 1 January, declared that:

“We have a proven and highly popular customer proposition. During difficult economic times, restaurants that offer great, consistent food at competitive price points will be the winners, and we sit comfortably in this space.”

It goes without saying that times have been tough out there in the hospitality sector over the last six months or so. 

Therefore the confidence of Morris rings more hopeful than many would have expected.

The £35m capitalised Tortilla Mexican Grill group now has some 82 fast-casual sites worldwide selling freshly made Californian-inspired Mexican cuisine, 65 of which are in the UK operated by the group, 9 are franchised out in the UK and 8 are franchised sites in the Middle East.

The last year was one of high resilience, especially in the face of so many challenges.

The group stated that it was helped by the ongoing strength of its customer proposition and the demand for its sector-leading brands.

Despite the Q4 rail strikes and weather disruptions the group actually saw a 16% like-for-like sales advance over the same period in 2019.

Analyst Anna Barnfather at Liberum Capital rates the group’s shares as a Buy at the current 87p, with a Target Price of 170p.

Her estimates for the last year suggest sales of £58.4m (£48.1m) and an EBITDA of £4.0m (£8.7m).

For the current year Barnfather is going for £69.8m takings and an EBITDA of £5.0m.

The ability of the group to fund itself through current pressures is seen by her estimate of current year end cash of £2.3m (est £0.4m debt).

The group’s management remains confident in its outlook for this year and beyond, and its ability to continue to implement its proven growth strategy. 

Richard Morris stated that:

“Looking ahead, we remain as motivated and enthusiastic as ever about Tortilla’s significant organic growth opportunities in the UK, with the added excitement of growing our already successful franchise partnerships both in the UK and abroad.”

Understandably, with so many external pressures over which its management had no control, this group has withstood and now is ready to push forward again.

The group’s shares reflect the balance sheet ability to resume growth and the continuation of new sites and franchises being rolled out this year.

New standard listing: Streaks Gaming sets sights on US growth

Conversational gaming company Streaks Gaming has raised cash to develop its platform. The initial games will be knowledge-based and be played between AI-generated digital personalities. Initial income will be generated from introducing people to sports betting firms, so Streaks Gaming is effectively a marketing business.
The US online sports betting market is growing rapidly as more states legalise this form of gambling. Morgan Stanley believes that the US market could be worth $8.5bn by 2025 and there are higher estimates.
Although £3m was raised, Aquis-quoted AQRU (LON: AQRU) invested £2.3m ...

Aquis weekly movers: Hydrogen Utopia confirms standard switch

Hydrogen Utopia International (LON: HUI) confirmed that the FCA has approved its admission to the standard list, and this is set to happen on 9 January. The share price rose 10.8% to 16.625p.

Steen Andersen became chief executive of probiotics products developer ProBiotix Health (LON: PBX) at the beginning of 2023. Revenues are improving and a trading statement will be published in the next few months. Product ranges are expanding and being launched in new countries. ProBiotix e-commerce revenues could be between £250,000 and £500,000 in 2023. The share price improved by 10.3% to 21.5p.

The pre-feasibility study for the Amapa iron ore project in Brazil, where Cadence Minerals (LON: KDNC) has a 30% stake in a joint venture that can be increased to 49%, indicates a capital cost of $399m to bring the mine back into production. Based on the cost estimates in the study, WH Ireland believes that at full production the mine could generate a profit contribution of $292m a year – based on iron ore prices of $100/t and $120/t depending on the grade. It believes the project could breakeven at an iron price of $85/t. The price is currently around $115/t. Chief executive Kiran Morzaria bought 45,454 shares at 11p each. The share price rose 6.43% to 12p on the week.

Marula Mining (LON: MARU) said it did not know why the share price had risen early in the week. It did fall back but remained 6% ahead at 4.4p. Management did note that there is increasing interest in its lithium, graphite and copper projects in Africa.

Fenikso Ltd (LON: FNK), which was previously called Lekoil, has completed the settlement agreements with Lekoil Nigeria Ltd and its former chief executive, as well as terminating arrangements with Savannah Energy (LON: SAVE). However, Lekoil Nigeria has been given additional time to surrender the 107.7 million shares it holds in Fenikso, which has no operating assets. The share price moved up by 2.74% to 0.75p.

==========

Fallers

AQRU (LON: AQRU) is the worst performer of the week falling 25.5% to 0.51p. It is an investor in Streaks Gaming (LON: STK), which has joined the standard list raising £3m at 3p a share and the share price ended the week at 3.5p (3p/4p). AQRU invested £2.3m in the placing.

Three brokers published notes on Invinity Energy Systems (LON: IES) last week. Forecast 2023 revenues were upgraded after recent contract wins. Canaccord Genuity and VSA both have buy recommendations and all three have target prices well above the current share price of 41p, down 4.65% on the week. Canaccord Genuity has the lowest target price of 75p.

Guanajuato Silver Company Ltd (LON: GSVR) has increased its proposed fundraising from C$7.5m to C$8.5m via an issue of units at C$0.425 each. The unit comprises one share and 0.5 of a warrant exercisable at C$0.60. A first tranche of C$6.8m has been issued and the rest should be issued by 10 January. The share price slipped 1.89% to 26p.

AIM weekly movers: GENinCode progresses towards US launch

3

Heart health diagnostics firm GENinCode (LON: GENI) has received California state licensing approval and CLIA certification for its laboratory in Irvine, California. The share price more than doubled, but profit-taking meant that it ended the week 88.4% higher at 14.6p. The certification will allow processing of Lipidin Code, which is set to be launched in the US first, and Cardioin Code tests. Lipid inCode diagnoses family hypercholesterolemia, which has a low rate of diagnosis with four-fifths of sufferers estimated to be undiagnosed. Cardio inCode focuses on genetic risk. There are plans to obtain FDA approval for Cardioin Code. There should be enough cash in the bank to last until the end of 2023.

hVIVO (LON: HVO) has secured a £5.2m contract with an Asia Pacific-based biotech company to test a vaccine in a Phase IIa study. The clinical trial will commence in the second half of 2023. This uses the company’s respiratory syncytial virus human challenge study. There are 95% of 2023 forecast revenues of £54m already contracted. The share price jumped 30% to 13p.

Hotel Chocolat (LON: HOTC) has signed a strategic partnership agreement with Tokyo-based Eat Creator Corporation, which will provide investment and expertise in Japanese food brand development. Hotel Chocolat will own 20% of the new company and receive brand royalty revenues. The new company will run the 21 Hotel Chocolat stores in Japan. The hare price recovered by 28% to 199p. The highest price since July.

Smart meter technology developer CyanConnode (LON: CYAN) gained an order for 983,525 Omnimesh modules and related hardware, plus a service and maintenance contract from Montecarlo. They will be installed in Madhya Pradesh, India. CyanConnode will commence deliveries in the first quarter. The order book in India is more than 3.6 million modules. The share price is 26.9% higher at 17.125p.

==========

Fallers

The Angle (LON: AGL) share price has slumped by 49.5% to 25.5p because revenues will be lower than expected. Market conditions have hampered the cancer diagnostics company in securing partnerships and building the commercial use of the Parsortix cancer cells capture technology. Revenues will be just above £1m in 2022 after contract delays, while 2023 revenues have been downgraded from £5m to £3.9m. Cash was around £32m at the end of 2022 and that should last until the middle of 2024.

In-video game advertising technology company Bidstack (LON: BIDS) says that it has invoiced Azerion Technology, but it is not being paid and has received a termination notice from the company. Bidstack says that there is no entitlement to end the agreement and it is claiming damages. Azerion Technology has been in dispute since October and this deal was underpinning forecasts. The share price slumped 29.7% to 1.95p.

Helium One Global (LON: HE1) will not be able to procure the Exalo drilling rig as it had expected because the current user has taken up a 12-month option. This will delay exploration drilling, which was due to start in the first quarter of 2023. At the end of last year, Helium One Global raised £9.9m at 5p a share to finance a single exploration well in the Tai prospect in the Rukwa Basin, Tanzania. This will help to prove up a working helium system. There are alternative rigs that could be secured, but this will mean drilling commencing later in the year. The share price declined by 26.8% to 5.2p.

United Oil & Gas (LON: UOG) says that the ASW-1X exploration well in Egypt did not discover any hydrocarbons. The drilling rig will be moved to the ASH-8 development well. This is also on the Abu Sennan licence where United Oil & Gas has a 22% non-operating interest. The share price slumped by 24.1% to 1.025p.

Pathfinder Minerals (LON: PFP) says the option agreement for the sale of IM Minerals to Acumen Advisory has been extended to 31 January. Pathfinder Minerals also raised £500,000 at 0.5p a share. The share price is 21.1% lower at 0.375p.

FTSE 100 closes in on pre-pandemic highs after US jobs report

The FTSE 100 rallied on Friday and closed in on pre-pandemic levels after a robust US jobs number demonstrated strength in the worlds largest economy, at a time inflation rates have began to decline.

The FTSE 100 was trading at 7,689, up 0.71% at the time of writing. A close above 7,672 would be the highest closing level since before the start of the pandemic in 2020.

US futures were surging with the S&P 500 up 1% and NASDAQ up 1.05%.

London-listed equities tracked a US equities higher as investors digested a US jobs report that showed the US unemployment rate falling alongside lower average wage growth, while the headline Non-Farm Payrolls beat expectations.

The US economy added 223,000 jobs in December, beating analyst estimates of 203,000 jobs added.

The Federal Reserve is now contending with falling inflation in a healthy economy, apparently able to withstand high prices and sharply higher interest rates. US CPI data due next week will be closely watched for confirmation of a trend to the downside in inflation figures and hints of what the Fed will do next.

Shell & BP

The strong jobs number helped build on a FTSE 100 rally on Friday that started with strength in oil majors BP & Shell. Shell released an insight into their Q4 results on Friday highlighting strong performance in their gas divisions.

Shell was 1.5% higher and BP was gaining 1.6% at the time of writing.

UK Retail spending

UK food retailers Sainsbury’s, Ocado and Tesco caught the interest of investors on Friday following Kantar data for the Christmas trading period earlier in week continued to provide support for the sector. Attractive results from Next and Greggs also provided evidence of a resilient UK consumer during December.

Tesco is set to report Christmas trading 13th January and Sainbury’s will release their figures 11th January.